Drug
Alfuzosin clinical trials
Also written Xatral and SL770499.
Keep track of what changes. Save the alfuzosin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
35 studies that test it; most in 2006 (11)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 5 |
| 2006 | 11 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 21 · Other 14
Sanofi (18) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Samsung Medical Center (1) · University Hospitals Cleveland Medical Center (1) · Asan Medical Center (1) · Mayo Clinic (1) · Chesapeake Urology Research Associates (1) · Kocatepe University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses alfuzosin is read from its arms, and is right about nine times in ten.
Testing it · 35
- Multiple Dose, Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets Under Fed ConditionsNot yet recruitingPhase 1Pharma NuevaNCT06316336Written as Alfuzosin Hydrochloride 10 mg
- The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed ConditionsNot yet recruitingPhase 1International Bio serviceNCT06228339Written as Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets
- Evaluation of Symptom-specific Goal AchievementCompletedPhase 4Samsung Medical CenterNCT00836823Written as Alfuzosin
- Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)CompletedNot applicableUniversity Hospitals Cleveland Medical CenterNCT00256399Written as Alfuzosin 10 mg
- The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH PatientsCompletedPhase 4Asan Medical CenterNCT00696761Written as Alfuzosin
- Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain SyndromeCompletedPhase 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00103402Written as Alfuzosin
- Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal FunctionsCompletedPhase 2Mayo ClinicNCT01834729Written as Alfuzosin
- An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract SymptomsCompletedPhase 3Chesapeake Urology Research AssociatesNCT00893113Written as Alfuzosin
- The Effects of α-adrenergic Receptor Antagonists on Choroid and PupilCompletedPhase 4Kocatepe UniversityNCT03144596Written as Alfuzosin Hydrochloride 10 MG
- Use of Alfuzosin in Stone Treatment With ESWLWithdrawnPhase 3Singapore General HospitalNCT00388271Written as Alfuzosin (Xatral)
- A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney StonesWithdrawnNot applicableUnity Health TorontoNCT00583258Written as Alfuzosin (Xatral)
- Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder DysfunctionCompletedPhase 3SanofiNCT00549939Written as Alfuzosin
- Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic EtiologyCompletedPhase 3SanofiNCT00576823Written as Alfuzosin
- Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02266537Written as Alfuzosin
- Alfuzosin Hydrochloride to Relieve Ureteral Stent DiscomfortCompletedPhase 3University of MinnesotaNCT00467467Written as Alfuzosin Hydrochloride
- Alfuzosin for Medical Expulsion Therapy of Ureteral StonesStatus unknownPhase 3United States Naval Medical Center, San DiegoNCT00713739Written as Alfuzosin
- Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)TerminatedPhase 2/3Nova Scotia Health AuthorityNCT00688948Written as Alfuzosin
- ALF-ONE : ALFuzosin ONcE DailyCompletedPhase 4SanofiNCT00280605Written as Alfuzosin
- Benign Prostatic Hyperplasia in TaiwanCompletedNot applicableSanofiNCT00941343Written as Alfuzosin (XATRAL® - SL770499)
- Minimally Invasive Surgical Therapy for BPHTerminatedPhase 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00064649Written as Finasteride and Alfuzosin
See all 35 studies that test alfuzosin →
Given in every arm · 1 — alfuzosin is usual care beside what is tested
Codes
What other systems call alfuzosin · ClinicalTrials.gg INT003252
- MeSH (NLM) C047638alfuzosinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 90347YTW5FALFUZOSINConfirmed FDA, NLM, Wikidata
- RxNorm 17300Confirmed FDA, Wikidata
- Wikidata Q2736873alfuzosinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61627AlfuzosinOne source FDA
- DrugBank DB00346One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C047638 | alfuzosin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 90347YTW5F | ALFUZOSIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 17300 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2736873 | alfuzosin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61627 | Alfuzosin | One source FDA |
| DrugBank | DB00346 | — | One source Wikidata |
Also registered as alfuzosin hydrochloride (UNII 75046A1XTN · RxNorm 46043).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.